Pegylated recombinant human arginase i bct-100

Pegylated recombinant human arginase i bct-100 Uses, Dosage, Side Effects, Food Interaction and all others data.

Pegylated recombinant human arginase i bct-100 is under investigation in clinical trial NCT03455140 (A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)).

Trade Name Pegylated recombinant human arginase i bct-100
Generic Pegylated Recombinant Human Arginase I
Pegylated Recombinant Human Arginase I Other Names Pegylated recombinant human arginase i bct-100
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Pegylated recombinant human arginase i bct-100
Pegylated recombinant human arginase i bct-100

Innovators Monograph

You find simplified version here Pegylated recombinant human arginase i bct-100


*** Taking medicines without doctor's advice can cause long-term problems.
Share